Harrington Investments, Inc Novo Nordisk A S Transaction History

Harrington Investments, Inc

  • $181 Million
  • Q3 2024

A detailed history of Harrington Investments, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Harrington Investments, Inc holds 26,095 shares of NVO stock, worth $2.68 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
26,095
Previous 27,190 4.03%
Holding current value
$2.68 Million
Previous $3.88 Million 19.94%
% of portfolio
1.72%
Previous 2.23%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
SELL
$119.07 - $145.42 $130,381 - $159,234
-1,095 Reduced 4.03%
26,095 $3.11 Million
Q2 2024

Aug 06, 2024
SELL
$122.71 - $146.91 $420,649 - $503,607
-3,428 Reduced 11.2%
27,190 $3.88 Million
Q1 2024

Apr 26, 2024
SELL
$102.11 - $135.92 $132,334 - $176,152
-1,296 Reduced 4.06%
30,618 $3.93 Million
Q4 2023

Jan 17, 2024
SELL
$87.78 - $105.45 $233,494 - $280,497
-2,660 Reduced 7.69%
31,914 $3.3 Million
Q3 2023

Oct 19, 2023
BUY
$90.94 - $199.54 $1.55 Million - $3.39 Million
17,001 Added 96.75%
34,574 $3.14 Million
Q2 2023

Jul 20, 2023
SELL
$155.98 - $172.65 $8,578 - $9,495
-55 Reduced 0.31%
17,573 $2.84 Million
Q1 2023

Apr 28, 2023
SELL
$132.34 - $159.14 $14,557 - $17,505
-110 Reduced 0.62%
17,628 $2.81 Million
Q4 2022

Jan 11, 2023
SELL
$102.55 - $135.33 $13,023 - $17,186
-127 Reduced 0.71%
17,738 $0
Q2 2022

Jul 22, 2022
BUY
$103.24 - $121.81 $2,064 - $2,436
20 Added 0.11%
17,865 $1.99 Million
Q1 2022

Apr 26, 2022
SELL
$93.1 - $112.54 $3,537 - $4,276
-38 Reduced 0.21%
17,845 $1.98 Million
Q4 2021

Jan 21, 2022
SELL
$95.88 - $117.08 $27,325 - $33,367
-285 Reduced 1.57%
17,883 $2 Million
Q3 2021

Oct 28, 2021
SELL
$84.42 - $106.62 $8,442 - $10,662
-100 Reduced 0.55%
18,168 $1.74 Million
Q2 2021

Aug 03, 2021
SELL
$67.66 - $84.76 $10,149 - $12,714
-150 Reduced 0.81%
18,268 $1.53 Million
Q1 2021

Apr 30, 2021
SELL
$67.06 - $75.82 $2,481 - $2,805
-37 Reduced 0.2%
18,418 $1.24 Million
Q4 2020

Jan 13, 2021
SELL
$63.89 - $73.8 $69,448 - $80,220
-1,087 Reduced 5.56%
18,455 $1.29 Million
Q3 2020

Oct 21, 2020
SELL
$63.69 - $70.22 $89,166 - $98,308
-1,400 Reduced 6.69%
19,542 $1.36 Million
Q2 2020

Jul 21, 2020
BUY
$58.54 - $67.94 $1,463 - $1,698
25 Added 0.12%
20,942 $1.37 Million
Q1 2020

May 07, 2020
SELL
$49.46 - $64.78 $8,655 - $11,336
-175 Reduced 0.83%
20,917 $1.26 Million
Q4 2019

Feb 10, 2020
SELL
$49.86 - $58.26 $49,760 - $58,143
-998 Reduced 4.52%
21,092 $1.22 Million
Q3 2019

Nov 05, 2019
SELL
$47.54 - $53.43 $5,942 - $6,678
-125 Reduced 0.56%
22,090 $1.14 Million
Q2 2019

Aug 07, 2019
SELL
$46.79 - $52.47 $935 - $1,049
-20 Reduced 0.09%
22,215 $1.13 Million
Q1 2019

Apr 29, 2019
SELL
$46.36 - $52.63 $72,553 - $82,365
-1,565 Reduced 6.58%
22,235 $1.16 Million
Q4 2018

Feb 01, 2019
SELL
$41.54 - $47.25 $14,539 - $16,537
-350 Reduced 1.45%
23,800 $1.1 Million
Q3 2018

Oct 25, 2018
SELL
$46.76 - $51.24 $30,394 - $33,306
-650 Reduced 2.62%
24,150 $1.14 Million
Q2 2018

Oct 19, 2018
SELL
$44.29 - $50.42 $104,081 - $118,487
-2,350 Reduced 8.66%
24,800 $1.14 Million
Q1 2018

Apr 12, 2018
BUY
$48.49 - $58.14 $14,062 - $16,860
290 Added 1.08%
27,150 $1.34 Million
Q4 2017

Feb 01, 2018
SELL
$47.53 - $53.73 $11,169 - $12,626
-235 Reduced 0.87%
26,860 $1.44 Million
Q3 2017

Oct 23, 2017
BUY
$41.15 - $49.22 $1.11 Million - $1.33 Million
27,095
27,095 $1.31 Million

Others Institutions Holding NVO

# of Institutions
1,952
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Harrington Investments, Inc Portfolio

Follow Harrington Investments, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrington Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harrington Investments, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email